Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 4,390 shares at $23.59 ($104K) on 2025-01-22, disclosed to the SEC on 2025-01-24.
Open-market sale of $104k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.59 | 2,195 | $52K | 50.0% |
| 2 | $23.59 | 2,195 | $52K | 50.0% |
| Total | $23.59 avg | 4,390 | $104K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |